LABU:ARCA-Direxion Daily S&P Biotech Bull 3X Shares (USD)

ETF | Trading--Leveraged Equity | NYSE Arca

Last Closing

USD 106.75

Change

-4.15 (-3.74)%

Market Cap

USD 0.28B

Volume

1.56M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

The investment seeks daily investment results, before fees and expenses, of 300% of the performance of the S&P Biotechnology Select Industry Index ("index"). The fund normally creates long positions by investing at least 80% of its assets in the securities that comprise the index and/or financial instruments that provide leveraged and unleveraged exposure to the index. The index is designed to measure the performance of a sub-industry or group of sub-industries determined based on the Global Industry Classification Standards ("GICS"). The fund is non-diversified.

Inception Date: 28/05/2015

Primary Benchmark: S&P Biotechnology Select Industry TR USD

Primary Index: S&P 500 TR USD

Gross Expense Ratio: 1.05%

Management Expense Ratio: 1.14 %

Unadjusted Closing Price

Adjusted Closing Price

Assets

N/A

Top Holdings

N/A

Top Sectors

N/A

Top Regions

N/A

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-06-17 )

Largest Industry Peers for Trading--Leveraged Equity

Symbol Name Mer Price(Change) Market Cap
SOXL Direxion Daily Semiconductor B.. 1.10 %

+2.08 (+3.91%)

USD 10.55B
QLD ProShares Ultra QQQ 0.95 %

+2.23 (+2.28%)

USD 7.08B
FNGU MicroSectors FANG+ Index 3X Le.. 0.00 %

+17.38 (+4.26%)

USD 5.87B
SSO ProShares Ultra S&P500 0.90 %

+0.68 (+0.83%)

USD 5.44B
SPXL Direxion Daily S&P500® Bull 3.. 1.00 %

+1.37 (+0.94%)

USD 4.69B
TECL Direxion Daily Technology Bull.. 1.17 %

+4.87 (+5.24%)

USD 3.65B
UPRO ProShares UltraPro S&P500 0.92 %

+0.85 (+1.11%)

USD 3.54B
FAS Direxion Daily Financial Bull .. 1.04 %

-2.94 (-2.80%)

USD 2.16B
TNA Direxion Daily Small Cap Bull .. 1.10 %

-0.53 (-1.47%)

USD 1.99B
USD ProShares Ultra Semiconductors 0.95 %

+9.81 (+7.41%)

USD 1.34B

ETFs Containing LABU

N/A

Market Performance

  Market Performance vs. Industry/Classification (Trading--Leveraged Equity) Market Performance vs. Exchange (NYSE Arca)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -12.48% 15% F 15% F
Dividend Return 0.13% 23% F 4% F
Total Return -12.35% 15% F 14% F
Trailing 12 Months  
Capital Gain -23.20% 14% F 11% F
Dividend Return 0.42% 16% F 4% F
Total Return -22.78% 12% F 10% F
Trailing 5 Years  
Capital Gain -89.17% 3% F 2% F
Dividend Return 0.17% 2% F 1% F
Total Return -89.00% 3% F 2% F
Average Annual (5 Year Horizon)  
Capital Gain 8.61% 39% F 68% D+
Dividend Return 8.68% 37% F 61% D-
Total Return 0.07% 6% D- 2% F
Risk Return Profile  
Volatility (Standard Deviation) 352.57% 12% F 2% F
Risk Adjusted Return 2.46% 21% F 30% F
Market Capitalization 0.28B 85% B 56% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.